| Local sharing as a predominant determinant of synaptic matrix molecular dynamics S Tsuriel, R Geva, P Zamorano, T Dresbach, T Boeckers, ... PLoS biology 4 (9), e271, 2006 | 211 | 2006 |
| Exchange and redistribution dynamics of the cytoskeleton of the active zone molecule bassoon S Tsuriel, A Fisher, N Wittenmayer, T Dresbach, CC Garner, NE Ziv Journal of Neuroscience 29 (2), 351-358, 2009 | 69 | 2009 |
| Metastasis-entrained eosinophils enhance lymphocyte-mediated antitumor immunity S Grisaru-Tal, S Dulberg, L Beck, C Zhang, M Itan, S Hediyeh-Zadeh, ... Cancer Research 81 (21), 5555-5571, 2021 | 53 | 2021 |
| Nek1 shares structural and functional similarities with NIMA kinase E Feige, O Shalom, S Tsuriel, N Yissachar, B Motro Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1763 (3), 272-281, 2006 | 38 | 2006 |
| Multispectral labeling technique to map many neighboring axonal projections in the same tissue S Tsuriel, S Gudes, RW Draft, AM Binshtok, JW Lichtman nAture methods 12 (6), 547-552, 2015 | 25 | 2015 |
| Similar synapse elimination motifs at successive relays in the same efferent pathway during development in mice SH Sheu, JC Tapia, S Tsuriel, JW Lichtman Elife 6, e23193, 2017 | 14 | 2017 |
| Abnormal reinnervation of denervated areas following nerve injury facilitates neuropathic pain H Leibovich, N Buzaglo, S Tsuriel, L Peretz, Y Caspi, B Katz, S Lev, ... Cells 9 (4), 1007, 2020 | 10 | 2020 |
| Extracellular vesicle-derived DNA vs. cfDNA as a biomarker for the detection of colon cancer K Thakur, MS Singh, S Feldstein-Davydova, V Hannes, D Hershkovitz, ... Genes 12 (8), 1171, 2021 | 9 | 2021 |
| Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An … N Peled, LC Roisman, E Levison, J Dudnik, E Chernomordikov, ... International Journal of Radiation Oncology* Biology* Physics 117 (1), 105-114, 2023 | 5 | 2023 |
| Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence S Borsekofsky, S Tsuriel, RR Hagege, D Hershkovitz Scientific Reports 13 (1), 13628, 2023 | 1 | 2023 |
| Digital PCR-Based Method for Detecting CDKN2A Loss in Brain Tumours S Tsuriel, V Hannes, A Hasona, M Raz, D Hershkovitz Molecular Diagnosis & Therapy 26 (6), 689-698, 2022 | 1 | 2022 |
| Spatial organization and early signaling of the B-cell receptor in CLL Y Shorer Arbel, Y Bronstein, T Dadosh, T Kamdjou, S Tsuriel, M Shapiro, ... Frontiers in immunology 13, 953660, 2022 | 1 | 2022 |
| The risk of PD-L1 expression misclassification in triple-negative breast cancer S Ben Dori, A Aizic, A Zubkov, S Tsuriel, E Sabo, D Hershkovitz Breast Cancer Research and Treatment 194 (2), 297-305, 2022 | 1 | 2022 |
| cfDNA NGS for Identification of Primary and Acquired Resistance in Patients With Lung Cancer and EGFR Mutations A Peleg, M Del Re, A Raphael, X Wang, A Berkovich, S Tsuriel, ... The Journal of Liquid Biopsy 1, 2023 | | 2023 |
| Artificial intelligence revolutionizes diagnosis in one of the world s deadliest cancers S Borsekofsky, S Tsuriel, RR Hagege, D Hershkovitz | | 2023 |
| Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients L Kampel, S Feldstein, S Tsuriel, V Hannes, NN Carmel Neiderman, ... Biomolecules 13 (9), 1418, 2023 | | 2023 |
| 133TiP Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study W Kian, N Peled, LC Roisman, E Levison, J Dudnik, E Chernomordikov, ... Journal of Thoracic Oncology 18 (4), S115, 2023 | | 2023 |
| Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study. N Peled, LC Roisman, E Levison, J Dudnik, E Chernomordikov, ... International Journal of Radiation Oncology, Biology, Physics, S0360-3016 …, 2023 | | 2023 |
| 951P Induction osimertinib followed by definitive sequential radiation therapy and/or surgery in unresectable EGFR-mutant stage III NSCLC: An open-label, single-arm, phase II study N Peled, LC Roisman, J Dudnik, E Dudnik, E Chernomordikov, ... Annals of Oncology 33, S982-S983, 2022 | | 2022 |
| Computational analysis of nuclear features as a grading tool for urothelial carcinoma I Fahoum, D Rattner, A Zubkov, A Greenberg, O Greenberg, R Naamneh, ... VIRCHOWS ARCHIV 481 (SUPPL 1), S21-S21, 2022 | | 2022 |
